A 30% surge in bioprocessing equipment orders, a new mRNA purification platform from Cytiva, and a frank discussion of tariff pressures make Danaher's latest earnings call required reading for lab leaders
From a next-gen cryo-EM to a smarter electronic pipette, the company's Q1 earnings call painted a detailed picture of where lab technology is heading — and what's putting pressure on budgets.